Study of Malformin C, a Fungal Source Cyclic Pentapeptide, as an Anti-Cancer DrugReport as inadecuate




Study of Malformin C, a Fungal Source Cyclic Pentapeptide, as an Anti-Cancer Drug - Download this document for free, or read online. Document in PDF available to download.

Malformin C, a fungal cyclic pentapeptide, has been claimed to have anti-cancer potential, but no in vivo study was available to substantiate this property. Therefore, we conducted in vitro and in vivo experiments to investigate its anti-cancer effects and toxicity. Our studies showed Malformin C inhibited Colon 38 and HCT 116 cell growth dose-dependently with an IC50 of 0.27±0.07μM and 0.18±0.023μM respectively. This inhibition was explicated by Malformin C’s effect on G2-M arrest. Moreover, we observed up-regulated expression of phospho-histone H2A.X, p53, cleaved CASPASE 3 and LC3 after Malformin C treatment, while the apoptosis assay indicated an increased population of necrotic and late apoptotic cells. In vivo, the pathological study exhibited the acute toxicity of Malformin C at lethal dosage in BDF1 mice might be caused by an acute yet subtle inflammatory response, consistent with elevated IL-6 in the plasma cytokine assay. Further anti-tumor and toxicity experiments proved that 0.3mg-kg injected weekly was the best therapeutic dosage of Malformin C in Colon 38 xenografted BDF1 mice, whereas 0.1mg-kg every other day showed no effect with higher resistance, and 0.9mg-kg per week either led to fatal toxicity in seven-week old mice or displayed no advantage over 0.3mg-kg group in nine-week old mice. Overall, we conclude that Malformin C arrests Colon 38 cells in G2-M phase and induces multiple forms of cell death through necrosis, apoptosis and autophagy. Malformin C has potent cell growth inhibition activity, but the therapeutic index is too low to be an anti-cancer drug.



Author: Jing Wang , Zaoli Jiang , Wing Lam, Elizabeth A. Gullen, Zhe Yu, Ying Wei, Lihui Wang, Caroline Zeiss, Amanda Beck, Ee-Chun Cheng

Source: http://plos.srce.hr/



DOWNLOAD PDF




Related documents